YOUR BUSINESS AUTHORITY
Springfield, MO
Amgen Inc. agreed to buy Celgene Corp.'s psoriasis treatment called Otezla for $13.4 billion.
The deal allows Bristol-Myers Squibb Co. to move forward on its acquisition of Celgene.
Otezla's sales were $1.6 billion last year.
Read more from The Wall Street Journal.
Nixa Superintendent Gearl Loden weighs in on A-F grade cards.
SBJ announces executive newsroom hires
Timeshare exit company owner sentenced for tax evasion
Trump, fast-food companies among targets of X redirects
Stockton district names next superintendent
State awards Springfield $4.6M for wastewater system improvements
Council modifies data center definitions bill, extends moratorium into next year